Pamela L. Ferguson

Pamela L. Ferguson

Auto-generated profile, based on publicly available information

Pamela L. Ferguson

Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Environmental Research
Verified
Journal Article
Closed access
MBMichael Bloom
Michael Bloom
SCSarah Commodore
Sarah Commodore
PFPamela L. Ferguson
Pamela L. Ferguson
BNBrian Neelon
Brian Neelon
JPJohn L. Pearce
John L. Pearce
KHKelly J. Hunt
Kelly J. Hunt

29 March 2022 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
VBVanessa Babineau
Vanessa Babineau
YFYaneve N. Fonge
Yaneve N. Fonge
EMEmily S. Miller
Emily S. Miller
WGWilliam A. Grobman
William A. Grobman
PFPamela L. Ferguson
Pamela L. Ferguson
CMCatherine Monk
Catherine Monk

15 March 2022 in Pediatric Obesity
Verified
Journal Article
Closed access
KHKelly J Hunt
Kelly J Hunt
PFPamela L. Ferguson
Pamela L. Ferguson
BNBrian Neelon
Brian Neelon
SCSarah Commodore
Sarah Commodore
MBMichael Bloom
Michael Bloom
EGECHO‐FGS Study Group
ECHO‐FGS Study Group

1 April 2022 in Childhood Obesity
Verified
Journal Article
Closed access
JHJanet S. Hildebrand
Janet S. Hildebrand
PFPamela L. Ferguson
Pamela L. Ferguson
ASAnthony C. Sciscione
Anthony C. Sciscione
WGWilliam A. Grobman
William A. Grobman
RNRoger B. Newman
Roger B. Newman
KHKelly J Hunt
Kelly J Hunt
Background: Studies suggest breastfeeding lowers obesity risk in childhood, but generalizability of existing evidence is limited. We examined associations of breastfeeding with childhood overweight, obesity, and percentage body fat, in a racially diverse maternal–child cohort. Methods: This cross-sectional study included 823 children, ages 4–8 years, enrolled in the Environmental Exposures and Child Health Outcomes (ECHO) cohort, a subset of the National Institute of Child Health and Human Development Fetal Growth Studies cohort. Logistic regression was used to estimate odds ratios and 95% confidence intervals (CIs) for overweight [BMI (kg/m2) 85th to <95th percentile] and obesity (BMI ≥95th percentile) in relation to breastfeeding including duration of exclusive and total breastfeeding. Linear regression was used to evaluate association between breastfeeding and percentage body fat measured by bioelectrical impedance analysis. Results: Fifty-two percent of children were male, 32% non-Hispanic Black, 29% Hispanic, 27% non-Hispanic White, and 13% Asian; 16% were overweight and 13% obese. Six months of exclusive breastfeeding, compared with no breastfeeding, was associated with 60% lower odds of obesity (95% CI 0.18–0.91) adjusting for age, gender, race, socioeconomic status, maternal BMI, and child's activity. Percentage body fat was inversely associated with breastfeeding duration. For none, <6, and ≥6 months of exclusive breastfeeding, adjusted mean percentage body fat was 16.8, 14.5, and 13.4, respectively. Results did not differ by gender, race/ethnicity, or maternal BMI status. Conclusions: Exclusive breastfeeding for the first 6 months of life is inversely and significantly associated with obesity and percentage body fat at ages 4–8 years. These findings support current breastfeeding guidelines.

6 March 2023 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
AKAnna Kirkland
Anna Kirkland
BBBrittney D. Browning
Brittney D. Browning
RGReJoyce Green
ReJoyce Green
HLHelen Liu
Helen Liu
AMAnna M. Maralit
Anna M. Maralit
LSLindsay M. Squeglia
Lindsay M. Squeglia
Current treatments for adolescent alcohol use disorder (AUD) are mainly psychosocial and limited in their efficacy. As such, pharmacotherapies are being investigated as potential adjunctive treatments to bolster treatment outcomes. N-acetylcysteine is a promising candidate pharmacotherapy for adolescent AUD because of its tolerability and demonstrated ability to modulate glutamatergic, GABAergic, and glutathione systems. The primary objective of this double-blind, placebo-controlled, within-subjects crossover preliminary investigation was to measure potential changes within glutamate + glutamine (Glx), GABA, and glutathione levels in the dorsal anterior cingulate cortex (dACC) using proton magnetic resonance spectroscopy during 10-days of N-acetylcysteine (1200 mg twice daily) compared to 10-days of placebo in non-treatment seeking adolescents who use alcohol heavily (N = 31; 55% female). Medication adherence was confirmed via video. Effects on alcohol use were measured using Timeline Follow-Back as an exploratory aim. Linear mixed effects models controlling for baseline metabolite levels, brain tissue composition, alcohol use, cannabis use, and medication adherence found no significant differences in Glx, GABA, or glutathione levels in the dACC after N-acetylcysteine compared to placebo. There were also no measurable effects on alcohol use; however, this finding was underpowered. Findings were consistent in the subsample of participants who met criteria for AUD (n = 19). The preliminary null findings in brain metabolite levels may be due to the young age of participants, relatively low severity of alcohol use, and non-treatment seeking status of the population investigated. Future studies can use these findings to conduct larger, well-powered studies within adolescents with AUD.

2 March 2024 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
AKAnna Kirkland
Anna Kirkland
RGReJoyce Green
ReJoyce Green
BBBrittney D. Browning
Brittney D. Browning
SAStephanie Aghamoosa
Stephanie Aghamoosa
DMDieter Meyerhoff
Dieter Meyerhoff
LSLindsay M. Squeglia
Lindsay M. Squeglia